Biofilms and core pathogens shape the tumour microenvironment and immune phenotype in colorectal cancer
L. Kvich, B. G. Fritz, H. Zschach, T. Terkelsen, H. Raskov, K. Hoest-Rasmussen, M. R. Jakobsen, A. G. Gheorghe, I. Gogenur, T. Bjarnsholt
Abstract
ObjectiveGrowing evidence links bacterial dysbiosis with colorectal cancer (CRC) carcinogenesis, characterized by an increased presence of core pathogens such as Bacteroides fragilis and Fusobacterium nucleatum. Here, we characterized the in situ biogeography and transcriptional interactions between bacteria and the host in mucosal colon biopsies. DesignThe influence of CRC core pathogens and biofilms on the tumour microenvironment (TME) was investigated in biopsies from patients with and without CRC (paired normal tissue and healthy tissue biopsies) using fluorescence in situ hybridization and dual-RNA sequencing. ResultsTissue-invasive, mixed-species biofilms enriched for B. fragilis and F. nucleatum were observed in CRC tissue, especially in right-sided tumours. Fusobacterium spp. was associated with increased bacterial biomass and inflammatory response in CRC samples. CRC samples with high bacterial activity demonstrated increased expression of pro-inflammatory cytokines, defensins, matrix-metalloproteases, and immunomodulatory factors. In contrast, the gene expression profiles of CRC samples with low bacterial activity resembled healthy tissue samples. Moreover, immune cell profiling showed that B. fragilis and F. nucleatum modulated the TME and correlated with increased infiltration of neutrophils and CD4+ T-cells. Overall, bacterial activity was critical for the immune phenotype and correlated with the infiltration of several immune cell subtypes, including M2 macrophages and regulatory T-cells. ConclusionBiofilms and core pathogens shape the TME and immune phenotype in CRC. Our results support that Fusobacterium spp. may provide a future therapeutic target to reduce biofilms and the inflammatory response in the TME while highlighting the importance of widening the scope of bacterial pathogenesis in CRC beyond core pathogens.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Fusobacterium nucleatum is enriched in invasive biofilms in colorectal cancer
Jessica Queen, Zam Cing, … Cynthia L. Sears·npj Biofilms and MicrobiomesPeer-reviewed·May 20, 2025
- A microfluidic model of colonocyte-microbiota interaction mimicking the colorectal cancer microenvironment
D. Penarete-Acosta, R. Stading, … A. Jayaraman·bioRxiv·Aug 29, 2023
- Bacterial lipopolysaccharide modulates immune response in the colorectal tumor microenvironment
A. K. Sulit, M. Daigneault, … R. Purcell·bioRxiv·Apr 26, 2022
- Significant and conflicting correlation of IL-9 with Prevotella and Bacteroides in human colorectal cancer
E. Niccolai, E. Russo, … A. Amedei·bioRxiv·Apr 28, 2020
- Virulence genes are a signature of the microbiome in the colorectal tumor microenvironment
Michael B Burns, Joshua Lynch, … Ran Blekhman·Genome MedicinePeer-reviewed·Jun 24, 2015
- Keystone pathobionts associated with colorectal cancer promote oncogenic reprograming
J. Jones, Q. Shi, … I. L. Brito·bioRxiv·Apr 3, 2023